Oncology (Williston Park, N.Y.)
Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed PD-L1-Positive Metastatic NSCLC.
Omar K Abughanimeh Mbbs, Anthony E Maida Iii PhD Ma Mba, Sanjive Qazi PhD, Kate-Lynn Muir DO, Bhavina Sharma, Lynette Smith PhD, Apar Kishor Ganti
Published: 202510.46883/2025.25921056
No abstract available for this study.